Our Lasers

Corporate Headquarters

Clinic Locator

Careers

Introduction to the TLC-1000 Cold Laser

Roger White explains the TLC-1000 technology

The Theralase super pulsed laser system can penetrate up to 4" into tissue, to promote cellular regeneration at the source of the injury and is the only laser on the market known to activate all three Cellular Pathways.

Theralase has been manufacturing super pulsed laser technology for 17 years, distributing this technology in Canada, the United States and Internationally.

Evidence based:

Technology and protocols based on solid clinical research by our team of clinical and scientific researchers and the feedback of thousands of health care clinics worldwide.

Clinical Research:

On-going, cutting-edge clinical research at Princess Margaret Hospital, University of Buffalo and Virginia Tech University.

Advisory Board:

Medical advisory board chaired by renowned orthopedic surgeon Dr. James Andrews and consisting of elite practitioners Dr. Jeff Dugas, Dr. Lyle Cain and Kevin Wilk .

Results Driven:

Over 1,000,000 patients successfully treated, with 1000's of Theralase lasers sold to satisfied health care providers.

World Class
Manufacturer:

Theralase complies with Health Canada, FDA, CE, ISO-13485 and CSA-601 regulatory approvals to ensure efficacy, safety and quality in manufacture.

Theralase vs Competitors

Explains The Advantages Of Theralase Technology Over The Competitive Technology.